^ Fusar-Poli, Paolo; Crippa, José A.; Bhattacharyya, Sagnik; Borgwardt, Stefan J.; Allen, Paul; Martin-Santos, Rocio; Seal, Marc; Surguladze, Simon A.; O'Carrol, Colin; Atakan, Zerrin; Zuardi, Antonio W.; McGuire, Philip K. (2009). "Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing". Archives of General Psychiatry. 66 (1): 95–105. doi:10.1001/archgenpsychiatry.2008.519. PMID 19124693.
Without arguing the merits of the above contentions, we point out that the legitimate use of hemp for non-intoxicant purposes has been inhibited by the continuing ferocious war against drug abuse. In this atmosphere, objective analysis has often been lacking. Unfortunately both proponents and opponents have tended to engage in exaggeration. Increasingly, however, the world is testing the potential of hemp in the field and marketplace, which surely must be the ultimate arbiters. De Guzman (2001), noting the pessimistic USDA report, observed that “Nevertheless, others point to the potential of [the] market. Hemp products have a growing niche market of their own, and the market will remain healthy and be well supported with many competing brands.”
In the 1970s, President Nixon declared a “War on Drugs” and signed into law the Controlled Substances Act of 1970. This law established a set of banned drugs and created the Drug Enforcement Administration (DEA). It also unintentionally outlawed one of the world’s oldest domesticated crop, hemp. This not only led to the demise of hemp, but also an increased misconception of the plant.
Short-term use increases both minor and major adverse effects.[104] Common side effects include dizziness, feeling tired, vomiting, and hallucinations.[104] Long-term effects of cannabis are not clear.[106] Concerns including memory and cognition problems, risk of addiction, schizophrenia in young people, and the risk of children taking it by accident.[103]

Environmental sex determination is known to occur in a variety of species.[39] Many researchers have suggested that sex in Cannabis is determined or strongly influenced by environmental factors.[27] Ainsworth reviews that treatment with auxin and ethylene have feminizing effects, and that treatment with cytokinins and gibberellins have masculinizing effects.[15] It has been reported that sex can be reversed in Cannabis using chemical treatment.[40] A PCR-based method for the detection of female-associated DNA polymorphisms by genotyping has been developed.[41]
There’s no definite amount that’s appropriate for everyone, but the ratio of CBD to THC will indicate how psychoactive the product is and if it’s legal in your state. The more CBD compared with THC, the less of a high, and vice versa. “Managing psychoactivity is key to successful cannabis therapy,” says Lee. “Amounts should be made clear on the label and lab-certified so people know what’s helping them and what’s not.”
In 2015, The Hebrew University of Israel published a study that documented the potency of single-molecule CBD extract versus the potency of whole-plant CBD-rich extract. It found that extract taken from whole plant CBD-rich cannabis is therapeutically superior to single-molecule extract. The scientists behind this study noticed that science had been utilizing pure, single-molecule CBD, which resulted in a bell-shaped dose-response curve. This means that CBD’s efficacy plummets at very high and very low doses.
Intraday Data provided by SIX Financial Information and subject to terms of use. Historical and current end-of-day data provided by SIX Financial Information. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.

Consumers report using CBD for a huge variety of health and wellness reasons, but a lot more research is needed to determine which symptoms and ailments it works best for. Currently, there are more than 40 clinical trials enrolling patients to examine the effectiveness of CBD for a variety of diseases, including substance use disorder, chronic pain, post-traumatic stress disorder (PTSD), depression, schizophrenia, and many others. Most importantly, CBD is incredibly safe, and not addictive. Even young children can tolerate daily doses of up to twenty milligrams (20 mg) per kilogram (1 kg) of body weight (for a 175 pound adult, that’s more than 1,500 mg). The most common side effect of high-dose CBD is sleepiness.
While the FDA has prevented any wide scale studies on the effectiveness of phytocannabinoid from being performed in the US, international studies suggest that it may help with a whole range of health conditions, such as anxiety, seizures, convulsions, inflammation, chronic pain, and more. The Innovet team has seen, through personal experiences and countless customer success stories, the lifesaving effects of phytocannabinoid oil.
Ten years ago hemp cultivation was illegal in Germany, England, Canada, Australia, and other countries. Essential to overcoming governmental reluctance in each country was the presentation of an image that was business-oriented, and conservative. The merits of environmentalism have acquired some political support, but unless there is a reasonable possibility that hemp cultivation is perceived as potentially economically viable, there is limited prospect of having anti-hemp laws changed. Strong support from business and farm groups is indispensable; support from pro-marijuana interests and what are perceived of as fringe groups is generally counterproductive. It is a combination of prospective economic benefit coupled with assurance that hemp cultivation will not detrimentally affect the enforcement of marijuana legislation that has led most industrially advanced countries to reverse prohibitions against growing hemp. Should the US permit commercial hemp cultivation to resume, it will likely be for the same reasons.
It is clear that there is a culture of idealistic believers in hemp in North America, and that there is great determination to establish the industry. As history has demonstrated, unbridled enthusiasm for largely untested new crops touted as gold mines sometimes leads to disaster. The attempt to raise silk in the US is probably the most egregious example. In 1826 a Congressional report that recommended the preparation of a practical manual on the industry resulted in a contagious desire to plant mulberries for silk production, with the eventual collapse of the industry, the loss of fortunes, and a legacy of “Mulberry Streets” in the US (Chapter 2, Bailey 1898). In the early 1980s in Minnesota, Jerusalem artichoke was touted as a fuel, a feed, a food, and a sugar crop. Unfortunately there was no market for the new “wonder crop” and hundreds of farmers lost about $20 million (Paarlberg 1990). The level of “hype” associated with industrial hemp is far more than has been observed before for other new crops (Pinfold Consulting 1998). Probably more so than any plant in living memory, hemp attracts people to attempt its cultivation without first acquiring a realistic appreciation of the possible pitfalls. American presidents George Washington and Thomas Jefferson encouraged the cultivation of hemp, but both lost money trying to grow it. Sadly in Canada in 1999 numerous farmers contracted to grow half of Canada’s crop area for hemp for the American-based Consolidated Growers and Processors, and with the collapse of the firm were left holding very large amounts of unmarketable grain and baled hemp straw. This has represented a most untimely setback for a fledgling industry, but at least has had a sobering effect on investing in hemp. In this section we emphasize why producers should exercise caution before getting into hemp.
As a physical therapist I have access to many modalities for pain. Specifically back pain that is not a radicular pain ( think disc problems) but sore muscle sprain/strain is common. Of all the modalities I have used, CBD transdermal is one of the most effective treatments. Pain just melts away in a matter of minutes without any smell or sensation.
Finding cultivars suited to local conditions is a key to success. Hemp prefers warm growing conditions, and the best European fiber strains are photoperiodically adapted to flowering in southern Europe, which provides seasons of at least 4 months for fiber, and 5.5 months for seed production. Asian land races are similarly adapted to long seasons. In Canada, many of the available cultivars flower too late in the season for fiber production, and the same may be predicted for the northern US. Fiber production should also be governed by availability of moisture throughout the season, and the need for high humidity in the late summer and fall for retting, so that large areas of the interior and west of North America are not adapted to growing fiber hemp. The US Corn Belt has traditionally been considered to be best for fiber hemp. There are very few cultivars dedicated to oilseed production (such as ‘Finola’ and ‘Anka’) or that at least are known to produce good oilseed crops (such as ‘Fasamo’ and ‘Uniko-B’). Oilseed production was a specialty of the USSR, and there is some likelihood that northern regions of North America may find short-season, short-stature oilseed cultivars ideal.
The most appropriate delivery system for CBD-rich cannabis is one that provides an optimal dose for a desired duration with as few unwanted side effects as possible. Medical cannabis products with CBD and low- or zero-levels of THC have very few noticeable side effects in pets – the most severe might be drowsiness. In addition, cannabis toxicity as a result of pet consumption of cannabis edibles is nonfatal and causes no known long-term side effects.
For epilepsy: A prescription cannabidiol product (Epidiolex) has been used. The recommended starting dose is usually 2.5 mg/kg twice daily (5 mg/kg/day). After one week the dose can be increased to 5 mg/kg twice daily (10 mg/kg/day). If the person doesn't respond to this dose, the maximum recommended is 10 mg/kg twice daily (20 mg/kg/day). In some research, higher doses of up to 50 mg/kg daily have been used. There is no strong scientific evidence that nonprescription cannabidiol products are beneficial for epilepsy.
More recent studies have focused on the mechanisms behind the schizophrenia–cannabis interaction. Epstein and Kumra (2014) tested the effect of cannabis on executive control of attention and cognitive function by comparing scores on the Attention Network Test among people with early-onset schizophrenia (EOS) and cannabis use disorder, only EOS, only cannabis use disorder, and controls. They found that the first group in particular had less efficient executive control of attention compared with those who had only EOS. They also found a smaller right caudal anterior cingulate cortex in subjects with EOS and cannabis use disorder. However, it is presently unclear whether this means that the smaller cortex surface leads to deficits in self-regulation and heavy cannabis use or if the direction of causation is in the opposite direction. More recent studies have suggested gene–environment correlation between cannabis use and schizophrenia in that the increased risk of schizophrenia after heavy and consistent cannabis use may be moderated by a shared gene that may explain part of the association (Power et al., 2014).
Zammit and colleagues’ findings were supported in a 3-year longitudinal study of the relationship between self-reported cannabis use and psychosis in a community sample of 4848 people in the Netherlands (van Os et al., 2002). Van Os and colleagues reported that cannabis use at baseline predicted an increased risk of psychotic symptoms during the follow-up period in individuals who had not reported psychiatric symptoms at baseline. There was a dose–response relationship between frequency of cannabis use at baseline and risk of psychotic symptoms during the follow-up period. These relationships persisted when they statistically controlled for the effects of other drug use. The relationship between cannabis use and psychotic symptoms was also stronger for cases with more severe psychotic symptoms.

The Gateway Hypothesis states that cannabis use increases the probability of trying "harder" drugs. The hypothesis has been hotly debated as it is regarded by some as the primary rationale for the United States prohibition on cannabis use.[261][262] A Pew Research Center poll found that political opposition to marijuana use was significantly associated with concerns about health effects and whether legalization would increase marijuana use by children.[263]


Thank you for sharing your story. It is amazing the stories I have heard and the things you here the politicians debating over. The truth is out. They need to get over there guilty pride and pharmaceutical needs to be slapped down a few pegs. This is happening we just need to defend the corporations that back the oil, the pharma, any other corporation that doesn’t fight a health and balance model.

I work well under pressure, but being extremely busy at work has almost made me less productive—I'm constantly distracted by email, Slack, and the people around me, to the point where getting my work done becomes difficult. This week, however, I've found it easier to put my blinders on, block out all distractions (especially social distractions) and focus on one task at a time. I think this is partly related to the lessened anxiety—I feel more frazzled and off task when my anxiety is running high. It almost feels like a newfound sense of clarity and calm that enables me to focus.
But he wasn’t finished. In February of 1980, Dr. Mechoulam teamed up with South American researchers to publish a study regarding cannabis and epilepsy. This study is seen as one of the earliest double-blind studies of CBD on clinical subjects. The study Dr. Mechoulam and his team conducted included 16 people, many of whom were children, who all suffered from severe epilepsy. The results were startling: Every subject who received CBD experienced improvement in their condition with little to no side effects. This anticonvulsant study has since proven to be an integral milestone in the world of clinical marijuana research, but largely went unnoticed at the time.
There is still a lot we don’t know about CBD. More accurately, we know pretty much nothing definitive about CBD because of the bureaucratic minefield that is the U.S. drug classification system. Under federal law, marijuana is a schedule 1 drug — putting it on the same level as LSD, ecstasy, and heroin. Even if it won’t get someone high, a non-hemp CBD product might still be technically illegal under federal law. 
So I’d like to buy from your #1 pick King Kanine, but when I visit their site and a) it loads super slow, b) there is zero information on which dosage (75mg, 100mg, or 300mg) to get based on my dog size/weight (the only thing I could find was screenshots of the dosage charts on the product description page, but that seems to apply to all dog weights, so not very helpful). MediPets (your #2 pick), on the other hand, clearly explains this, so I went with them.

Since our pets is also now considered part of our family, it is also important to take care of them and give them the necessary needs in order to get longer life. Of course, these pets also provide us entertainment, love, care, and even attention especially if we are just at home. That is why making them feel loved by giving them their needs plus supplements to be healthier would also be beneficial for the owner.
Quality is a particular concern, because cannabis plants easily soak up heavy metals from pesticides and other contaminants, Marcu says. If you are buying online, look for a company that documents how it tests its products. (If the website doesn’t indicate this, call and ask.) “Buying from a reputable manufacturer is crucial, because it matters how the plant is cultivated and processed,” Dr. Maroon says. One clue that a company is cutting corners: too low a cost. Good CBD is pricey—a bottle of high-quality capsules is sold in Cohen’s office for $140. But for many, it’s worth the money. Roth spent $60 on her tiny bottle. But when her energy returned the day she started taking CBD, she decided that was a small price to pay.
Cannabis is indigenous to Central Asia[192] and the Indian subcontinent,[193] and its use for fabric and rope dates back to the Neolithic age in China and Japan.[194][195] It is unclear when cannabis first became known for its psychoactive properties; some scholars suggest that the ancient Indian drug soma, mentioned in the Vedas, was cannabis, although this theory is disputed.[196]
His parents took him to more than 20 doctors around the country, and he tried more than a dozen medications. Nothing worked. Two years ago, the Leydens were at the end of their rope. They decided to see whether marijuana might help. (Medical use of the drug is legal in the District, where they live, and the Leydens found a doctor willing to work with them.) In 2014, Jackson got his first dose of cannabis.

Cannabis is the most widely used illicit drug. Over 100 phytocannabinoids, as well as terpenoids, fatty acids, and other compounds with health relevance, have been found in Cannabis. The pharmacological importance of cannabinoids has been intensively studied. Multiple mechanisms of the effects of cannabinoids on the nervous system are being elucidated. Cannabinoids have anti-inflammatory, antioxidant, immunomodulatory, antimicrobial, and anticancer activities. Hemp seed oil and terpenoids have health-promoting effects. The relationship between Cannabis chemotype and genotype is being revealed by chemical and genetic analyses. Various omics platform facilitate the basic and applied studies of Cannabis plants. An expanded Cannabaceae family, which consists of six genera, is advocated. This chapter summarizes the recent research progress of phytochemistry, pharmacology, and omics of Cannabis plants.


In the United States, cannabis is overall the number four value crop, and is number one or two in many states including California, New York and Florida, averaging $3,000 per pound ($6,600/kg).[256][257] Some believe it generates an estimated $36 billion market.[258] Some have argued that this estimate is methodologically flawed, and makes unrealistic assumptions about the level of marijuana consumption. Other estimates claiming to correct for this flaw claim that the market is between $2.1-$4.3 billion.[249] The United Nations Office on Drugs and Crime claims in its 2008 World Drug Report that typical U.S. retail prices are $10–15 per gram (approximately $280–420 per ounce). Street prices in North America are known to range from about $40–$400 per ounce ($1.4–$14/g), depending on quality.[259]
Multiple sclerosis (MS). There is inconsistent evidence on the effectiveness of cannabidiol for symptoms of multiple sclerosis. Some early research suggests that using a cannabidiol spray under the tongue might improve pain and muscle tightness in people with MS. However, it does not appear to improve muscle spasms, tiredness, bladder control, the ability to move around, or well-being and quality of life.

Unfortunately, because this is a supplement we're not allowed to make medical claims regarding its use as a treatment or cure. However, this is the exact reason we began using this product on our own pets. (Our founding pets were diagnosed with cancer; one was 16 and the other was 8.) We used phytocannabinoidas palliative care for appetite and pain management.
But herein lies a problem. The research needed to determine the correct dosage for CBD oil in dogs simply hasn’t been done yet, Coates says. And, to make matters worse, FDA testing has shown that many CBD products contain little if any CBD, she adds. The best option available to pet parents at this time is to talk to a veterinarian who has experience with pets being treated with cannabis oil about proper dosage and reputable manufacturers, Coates says.
The Gateway Hypothesis states that cannabis use increases the probability of trying "harder" drugs. The hypothesis has been hotly debated as it is regarded by some as the primary rationale for the United States prohibition on cannabis use.[261][262] A Pew Research Center poll found that political opposition to marijuana use was significantly associated with concerns about health effects and whether legalization would increase marijuana use by children.[263]
On October 17, 2018, Canada legalized cannabis for recreational adult use[55] making it the second country in the world to do so after Uruguay and the first G7 nation.[56] The Canadian Licensed Producer system may become the Gold Standard in the world for safe and secure cannabis production,[57] including provisions for a robust craft cannabis industry where many expect opportunities for experimenting with different strains.[58] Laws around use vary from province to province including age limits, retail structure, and growing at home.[55]
I work at Earthbound Trading Company, therefore discovering the CBD line. By far, one of my favorite products in our store! I had a nurse come in with chronic back pain and fibromyalgia. I recommended the CBD intensive cream. At a later date, she returned to the store to let me know that we sold her a miracle in a jar. She said that for the first time in years she was the most relaxed at work that she has ever been since she started nursing. She applied it while at work and said that she was pain free for 10 out of her 12 hour shift! I, myself, have been having some sharp, shooting back pain the last two weeks. The intensive cream has worked wonders! I applied it at one in the afternoon, and I was pain free for 12 hours! Plus, you can literally feel it working. Such an amazing product. You definitely can’t find that kind of pain relief over the counter or in your local pharmacy.
Arthritis is a disease of the joints that comes in many different forms and can cause mild discomfort to extreme pain. Typical symptoms include swelling, stiffness, and decreased range of motion. Just as it can be very discomforting or painful for us, arthritis also affects our dogs, especially as they get older. CBD works with the Vanilloid receptor to help reduce swelling and stiffness caused by inflammation while mediating your dog’s perception of pain.  This allows CBD to effectively combat arthritis, and keep your pup moving around happy and pain-free!
^ Klein C, Karanges E, Spiro A, Wong A, Spencer J, Huynh T, Gunasekaran N, Karl T, Long LE, Huang XF, Liu K, Arnold JC, McGregor IS (November 2011). "Cannabidiol potentiates Δ⁹-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats". Psychopharmacology. 218 (2): 443–457. doi:10.1007/s00213-011-2342-0. PMID 21667074.

It is for this reason that all the finished hemp goods that you see for sale in America, from food products to clothing to building materials, are part of an imported hemp industry that has surpassed $688 million annually. The size of this import industry is one of the major catalysts for hemp legalization in the U.S. As a renewable source of a range of products, hemp provides an exciting new step in American agriculture.


However, the medication that they need is not the same as what our medicines applies to us because there is still a difference in the body systems of each mammal. It was mentioned on researches that they haven’t found an effective cure for dogs with those kinds of diseases because each breed has also differenced in their defense systems inside their body. However, there has been recent news about a hemp cbd oil for dogs that was proven to be effective against seizures and other diseases that have no known cure yet.
A wide variety of hemp clothing, footwear, and food products are now available in North America. Some American manufacturers and distributors have chosen to exploit the association of hemp products with marijuana in their advertising. Such marketing is unfortunate, sending the message that some in the industry are indifferent to the negative image that this generates in the minds of much of the potential consuming public. Admittedly, such advertising works. But marketing based on the healthful and tasteful properties of hemp food products, the durable nature of hemp textiles, and the environmental advantages of the crop has proven to be widely acceptable, and is likely to promote the long term development of hemp industries.
But he wasn’t finished. In February of 1980, Dr. Mechoulam teamed up with South American researchers to publish a study regarding cannabis and epilepsy. This study is seen as one of the earliest double-blind studies of CBD on clinical subjects. The study Dr. Mechoulam and his team conducted included 16 people, many of whom were children, who all suffered from severe epilepsy. The results were startling: Every subject who received CBD experienced improvement in their condition with little to no side effects. This anticonvulsant study has since proven to be an integral milestone in the world of clinical marijuana research, but largely went unnoticed at the time.

Buy CBD

×